148 related articles for article (PubMed ID: 24186057)
1. Expression and clinical significance of carcinoembryonic antigen-related cell adhesion molecule 6 in breast cancers.
Tsang JY; Kwok YK; Chan KW; Ni YB; Chow WN; Lau KF; Shao MM; Chan SK; Tan PH; Tse GM
Breast Cancer Res Treat; 2013 Nov; 142(2):311-22. PubMed ID: 24186057
[TBL] [Abstract][Full Text] [Related]
2. The interaction between carcinoembryonic antigen-related cell adhesion molecule 6 and human epidermal growth factor receptor 2 is associated with therapeutic efficacy of trastuzumab in breast cancer.
Iwabuchi E; Miki Y; Kanai A; Miyashita M; Kijima G; Hirakawa H; Suzuki T; Ishida T; Sasano H
J Pathol; 2018 Nov; 246(3):379-389. PubMed ID: 30058236
[TBL] [Abstract][Full Text] [Related]
3. A marker of endocrine receptor-positive cells, CEACAM6, is shared by two major classes of breast cancer: luminal and HER2-enriched.
Balk-Møller E; Kim J; Hopkinson B; Timmermans-Wielenga V; Petersen OW; Villadsen R
Am J Pathol; 2014 Apr; 184(4):1198-208. PubMed ID: 24655379
[TBL] [Abstract][Full Text] [Related]
4. Carcinoembryonic antigen cell adhesion molecule 6 predicts breast cancer recurrence following adjuvant tamoxifen.
Maraqa L; Cummings M; Peter MB; Shaaban AM; Horgan K; Hanby AM; Speirs V
Clin Cancer Res; 2008 Jan; 14(2):405-11. PubMed ID: 18223215
[TBL] [Abstract][Full Text] [Related]
5. Overexpression and clinical significance of carcinoembryonic antigen-related cell adhesion molecule 6 in colorectal cancer.
Kim KS; Kim JT; Lee SJ; Kang MA; Choe IS; Kang YH; Kim SY; Yeom YI; Lee YH; Kim JH; Kim KH; Kim CN; Kim JW; Nam MS; Lee HG
Clin Chim Acta; 2013 Jan; 415():12-9. PubMed ID: 22975528
[TBL] [Abstract][Full Text] [Related]
6. Lymphocytic infiltrate is associated with favorable biomarkers profile in HER2-overexpressing breast cancers and adverse biomarker profile in ER-positive breast cancers.
Tsang JY; Hui SW; Ni YB; Chan SK; Yamaguchi R; Kwong A; Law BK; Tse GM
Breast Cancer Res Treat; 2014 Jan; 143(1):1-9. PubMed ID: 24272079
[TBL] [Abstract][Full Text] [Related]
7. Co-expression of carcinoembryonic antigen-related cell adhesion molecule 6 and 8 inhibits proliferation and invasiveness of breast carcinoma cells.
Iwabuchi E; Miki Y; Onodera Y; Shibahara Y; Takagi K; Suzuki T; Ishida T; Sasano H
Clin Exp Metastasis; 2019 Oct; 36(5):423-432. PubMed ID: 31222613
[TBL] [Abstract][Full Text] [Related]
8. Expression pattern of stromal cell-derived factor-1 chemokine in invasive breast cancer is correlated with estrogen receptor status and patient prognosis.
Kobayashi T; Tsuda H; Moriya T; Yamasaki T; Kikuchi R; Ueda S; Omata J; Yamamoto J; Matsubara O
Breast Cancer Res Treat; 2010 Oct; 123(3):733-45. PubMed ID: 20020198
[TBL] [Abstract][Full Text] [Related]
9. C4.4A highly expressed in HER2-positive human breast cancers may indicate a good prognosis.
Miyake T; Ito T; Yanai A; Inoue N; Miyagawa Y; Murase K; Imamura M; Ichii S; Takatsuka Y; Nishizaki T; Hirota S; Ohtsuka M; Yamamoto H; Noguchi S; Miyoshi Y
Breast Cancer; 2015 Jul; 22(4):366-73. PubMed ID: 23918676
[TBL] [Abstract][Full Text] [Related]
10. CEACAM6 gene expression in intrahepatic cholangiocarcinoma.
Ieta K; Tanaka F; Utsunomiya T; Kuwano H; Mori M
Br J Cancer; 2006 Aug; 95(4):532-40. PubMed ID: 16868542
[TBL] [Abstract][Full Text] [Related]
11. Protein expression analysis of ALCAM and CEACAM6 in breast cancer metastases reveals significantly increased ALCAM expression in metastases of the skin.
Ihnen M; Kilic E; Köhler N; Löning T; Witzel I; Hagel C; Höller S; Kersten JF; Müller V; Jänicke F; Milde-Langosch K
J Clin Pathol; 2011 Feb; 64(2):146-52. PubMed ID: 21262777
[TBL] [Abstract][Full Text] [Related]
12. CX3CL1 expression is associated with poor outcome in breast cancer patients.
Tsang JY; Ni YB; Chan SK; Shao MM; Kwok YK; Chan KW; Tan PH; Tse GM
Breast Cancer Res Treat; 2013 Aug; 140(3):495-504. PubMed ID: 23912959
[TBL] [Abstract][Full Text] [Related]
13. CEACAM5 and CEACAM6 are major target genes for Smad3-mediated TGF-beta signaling.
Han SU; Kwak TH; Her KH; Cho YH; Choi C; Lee HJ; Hong S; Park YS; Kim YS; Kim TA; Kim SJ
Oncogene; 2008 Jan; 27(5):675-83. PubMed ID: 17653079
[TBL] [Abstract][Full Text] [Related]
14. Expression of CEACAM6 in resectable colorectal cancer: a factor of independent prognostic significance.
Jantscheff P; Terracciano L; Lowy A; Glatz-Krieger K; Grunert F; Micheel B; Brümmer J; Laffer U; Metzger U; Herrmann R; Rochlitz C
J Clin Oncol; 2003 Oct; 21(19):3638-46. PubMed ID: 14512395
[TBL] [Abstract][Full Text] [Related]
15. Expression profiling of CEACAM6 associated with the tumorigenesis and progression in gastric adenocarcinoma.
Deng X; Liu P; Zhao Y; Wang Q
Genet Mol Res; 2014 Sep; 13(3):7686-97. PubMed ID: 25299082
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes.
Kim MJ; Ro JY; Ahn SH; Kim HH; Kim SB; Gong G
Hum Pathol; 2006 Sep; 37(9):1217-26. PubMed ID: 16938528
[TBL] [Abstract][Full Text] [Related]
17. Expression of carcinoembryonic antigen cell adhesion molecule 6 oncoprotein in atypical ductal hyperplastic tissues is associated with the development of invasive breast cancer.
Poola I; Shokrani B; Bhatnagar R; DeWitty RL; Yue Q; Bonney G
Clin Cancer Res; 2006 Aug; 12(15):4773-83. PubMed ID: 16899629
[TBL] [Abstract][Full Text] [Related]
18. Basal-HER2 phenotype shows poorer survival than basal-like phenotype in hormone receptor-negative invasive breast cancers.
Liu H; Fan Q; Zhang Z; Li X; Yu H; Meng F
Hum Pathol; 2008 Feb; 39(2):167-74. PubMed ID: 18045647
[TBL] [Abstract][Full Text] [Related]
19. Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer.
Rennstam K; McMichael N; Berglund P; Honeth G; Hegardt C; Rydén L; Luts L; Bendahl PO; Hedenfalk I
Breast Cancer Res Treat; 2010 Jul; 122(2):315-24. PubMed ID: 19795205
[TBL] [Abstract][Full Text] [Related]
20. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.
Pellikainen JM; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM
Clin Cancer Res; 2004 Nov; 10(22):7621-8. PubMed ID: 15569994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
